E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
CPRX holding history
Catalyst Pharmaceuticals, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,669
- Value
- $366.8K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,669 | $366.8K | <0.1% | −3,508−23.1% | Reduced | Holders |
| Q1 2026 | 15,177 | $375.8K | <0.1% | – | No prior filing | Holders |
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 10,656 | $231.2K | <0.1% | +871+8.9% | Added | Holders |
| Q1 2025 | 9,785 | $237.3K | <0.1% | +9,785 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −11,266−100.0% | Sold out | Holders |
| Q2 2024 | 11,266 | $174.5K | <0.1% | −11,737−51.0% | Reduced | Holders |
| Q1 2024 | 23,003 | $366.7K | <0.1% | +4,090+21.6% | Added | Holders |
| Q4 2023 | 18,913 | $317.9K | <0.1% | −7,307−27.9% | Reduced | Holders |
| Q3 2023 | 26,220 | $307.0K | <0.1% | −12,218−31.8% | Reduced | Holders |
| Q2 2023 | 38,438 | $517.0K | <0.1% | +12,059+45.7% | Added | Holders |
| Q1 2023 | 26,379 | $437.0K | <0.1% | +565+2.2% | Added | Holders |
| Q4 2022 | 25,814 | $480.0K | <0.1% | −2,011−7.2% | Reduced | Holders |
| Q3 2022 | 27,825 | $357.0K | <0.1% | +6,490+30.4% | Added | Holders |
| Q2 2022 | 21,335 | $150.0K | <0.1% | +9,721+83.7% | Added | Holders |
| Q1 2022 | 11,614 | $96.0K | <0.1% | +11,614 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −10,838−100.0% | Sold out | Holders |
| Q3 2021 | 10,838 | $57.0K | <0.1% | – | No prior filing | Holders |
| Q2 2021 | – | – | – | – | Not filed | Holders |
| Q1 2021 | 18,138 | $84.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.